Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-17

Clinical Trial Update: Risperidone and Zotepine in the Treatment of Delirium [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on risperidone and zotepine for delirium has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)
  • Zotepine (Zotepine)

Snippet

Sponsor: Changhua Christian Hospital | Conditions: Delirium | Phase 4 | Status: TERMINATED